HeyJaredElise Reuter
- Indexed articles, last 90 days
- 6
- Latest publication
- Sep 21, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 16, 2026
Latest articles
Oura seeks to raise up to $2.2B in IPO (opens the original)
Read excerpt
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Wearables firm Oura is seeking up to $2.2 billion in an initial public offering, the company disclosed in a Monday securities filing. While the IPO has not been priced yet, Oura estimates its shares will be valued at $40 to $44 each. Oura plans to offer 13.5 million shares of common stock, and selling stockholders plan to offer 36.5 million shares, for a t
Medtronic begins final steps to separate MiniMed (opens the original)
Read excerpt
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic said Monday that it has started an exchange offer to split off up to 80.1% of the shares of MiniMed. Formerly Medtronic's diabetes technology business, MiniMed went public in March as part of a two-step separation process. Exchanging the remainder of Medtronic's shares is the second part of the process. Medtronic currently owns 89.9% of the compa
5 takeaways from Oura’s IPO filing (opens the original)
Read excerpt
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Oura last week shared a glimpse of its finances ahead of a planned initial public offering. The maker of a wearable ring has not yet disclosed how much it plans to raise in the offering, but The Wall Street Journal reported last month that Oura could be valued at well over $11 billion. Here are some key numbers from Oura's prospectus to watch in its IPO. T
KKR to take Integer private for $5.7B (opens the original)
Read excerpt
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Global investment firm KKR said Monday it has agreed to buy device manufacturer Integer Holdings for about $5.7 billion. The companies expect to close the deal before the end of the year, at which point Integer would become a private company. Shares of Integer rose by nearly 20% to $121.21 Friday afternoon following a Wall Street Journal report that the tw
Tempus to buy cancer test maker Personalis for $1.5B (opens the original)
Read excerpt
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Tempus AI said Monday it has agreed to buy Personalis for $1.5 billion. Fremont, California-based Personalis makes a molecular residual disease test for cancer. Tempus expects the acquisition will allow it to better support patients around cancer diagnostics, treatment selection, recurrence and monitoring. The planned purchase follows recent interest in bl
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.